J.-C. Martel

Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety

Agnès L. Auclair, J.-C. Martel, M.B. Assié et al. · Neuropharmacology · 2013 · 259 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +17

Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys.

Pierre J. Blanchet, Frédéric Calon, J.-C. Martel et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 142 citations

Neurotransmitter and Receptor Deficits in Senile Dementia of the Alzheimer Type

Rémi Quirion, J.-C. Martel, Yves Robitaille et al. · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 1986 · 100 citations · Full text

Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra

Rémi Quirion, Pierrette Gaudreau, J.-C. Martel et al. · Brain Research · 1985 · 65 citations

Neurobiological Mechanism, Dopaminergic Systems, Basal Ganglia +15

Quantitative autoradiographic distribution of [125i]bolton-hunter neuropeptide y receptor binding sites in rat brain. comparison with [125i]peptide yy receptor sites

J.-C. Martel, Alain Fournier, S. St. Pierre et al. · Neuroscience · 1990 · 55 citations

Medicine, Hormonal Receptor, Neuroendocrine Mechanism +9